Premium-grade Retatrutide, Tirzepatide and research peptides for precision results. Fast delivery across Australia and New Zealand, trusted by researchers in both countries.
GLP1 Peptides AU proudly serves researchers across Australia and New Zealand — from Sydney to Auckland, Melbourne to Wellington. Same trusted quality, same fast delivery, on both sides of the Tasman.
GLP1 Peptides Australia is a trusted source for premium research peptides. Every order is backed by strict quality control and fast Australia-wide delivery.
Every batch tested and verified for consistent research-grade quality.
Discreet, tracked shipping to every state and territory in Australia.
PayID instant transfer and traditional bank transfer (BSB) accepted.
GLP1 Peptides AU is an Australian supplier of laboratory-grade research peptides, including Retatrutide, Tirzepatide, Ozempic, Wegovy, Zepbound, BPC-157, TB-500, GHK-Cu, and NAD+. If you've been searching for where to buy Retatrutide in Australia or looking for a reliable Tirzepatide research peptide supplier, our catalogue is built specifically for researchers based in Sydney, Melbourne, Brisbane, Perth, Adelaide, and every state and territory across the country.
Retatrutide is a triple agonist research compound that targets GLP-1, GIP, and glucagon receptor pathways. It's one of the most actively studied peptides in current metabolic research literature, and our Retatrutide research pens are supplied in 5mg, 6mg, 10mg, 12mg, 20mg, 30mg, and 40mg formats, including 2x bundle options for laboratories running extended research protocols. Retatrutide remains an investigational compound and is not approved by the TGA, FDA, or any regulator for human use.
Tirzepatide is a dual GIP/GLP-1 receptor agonist research compound, widely referenced in metabolic and endocrine research. Our Tirzepatide research pen kits are supplied at 20mg and 40mg for laboratory formulation, receptor-binding, and delivery-system research. In Australia, tirzepatide is only TGA-approved as a medicine under the brand Mounjaro, available exclusively by private prescription, our research-grade Tirzepatide is a separate product intended strictly for laboratory use.
Table for research reference only. Both compounds are supplied strictly for laboratory research and development — not for human use.
Alongside our core Retatrutide and Tirzepatide research lines, we supply a full range of GLP-1 receptor agonist research formulations referencing Mounjaro (2.5mg–15mg), Ozempic (0.25mg–2mg), Wegovy (0.25mg–2.4mg), and Zepbound (2.5mg–15mg) dosing structures. These are supplied as laboratory research compounds for metabolic pathway studies — not as substitutes for, or equivalents to, the prescription medicines of the same name, which remain TGA-regulated and available only via prescription in Australia.
Our Alluvi Healthcare range covers some of the most-referenced compounds in recovery and longevity peptide research: BPC-157 & TB-500 combination pens for tissue-repair pathway studies, GHK-Cu copper peptide for dermatological and collagen research, and NAD+ 1,000mg for cellular energy metabolism research. Each is supplied in pre-filled, sealed research pens with a certificate of analysis available on request.
Whether you're searching for Retatrutide for sale Australia, Tirzepatide research peptide Australia, buy Mounjaro research peptide online, Ozempic and Wegovy research compounds Australia, or highest purity Retatrutide Australia, our team ships discreetly nationwide with PayID and bank transfer accepted on every order.
GLP1 Peptides AU ships Retatrutide research peptides to every state and territory in Australia, including New South Wales, Victoria, Queensland, Western Australia, South Australia, Tasmania, the ACT, and the Northern Territory. All orders are dispatched with tracked, discreet delivery from our Australian facility.
Tirzepatide is a dual agonist acting on GIP and GLP-1 receptor pathways. Retatrutide is a triple agonist, adding glucagon receptor activity on top of GIP and GLP-1. Both are referenced extensively in current metabolic research literature, and we supply both as separate research-grade product lines.
Our Retatrutide and Tirzepatide research peptides are sold strictly for laboratory research and development use, not for human consumption. Retatrutide is investigational and unapproved by any regulator worldwide. Tirzepatide as a medicine is only TGA-approved under the brand Mounjaro by prescription, our research-grade product is a separate, non-therapeutic item.
Every batch of Retatrutide, Tirzepatide, and our wider peptide range is sourced and verified for laboratory-grade consistency, with certificates of analysis (COA) available on request.
Store refrigerated at 2–8°C and avoid freeze-thaw cycles, which can degrade peptide structure. Each order ships with a research information sheet covering handling and storage in more detail.
Yes, alongside Australia-wide delivery, we ship our full Retatrutide and Tirzepatide research peptide range to New Zealand, including Auckland, Wellington, Christchurch, and surrounding regions.
GLP1 Peptides AU ships to every state, territory and major city in Australia, plus key regions across New Zealand. Find local delivery info, dosing guides and FAQs for your area below.
